Advanced search
Publication Cover
Personalized Medicine Volume 9, 2012 - Issue 4
Submit an article Journal homepage
324
Views
1
CrossRef citations to date
0
Altmetric
Perspective

After the Revolution? Ethical and Social Challenges in ‘Personalized Genomic Medicine‘

Eric T Juengst1 University of North Carolina – Chapel Hill, Center for Bioethics, 333 MacNider Hall, Chapel Hill, NC27599–7240, USA. Correspondence[email protected]
View further author information
,
Richard A Settersten2 Oregon State University, College of Public Health & Human Sciences, 2631 SW Campus Way (HFC), Corvallis, OR97331–5102, USAView further author information
,
Jennifer R Fishman3 McGill University, Social Studies of Medicine Department, Biomedical Ethics Unit, 3647 Peel Street, 307, Montreal, QCH3A 1X1, CanadaView further author information
&
Michelle L McGowan4 Case Western Reserve University, School of Medicine, Department of Bioethics, 10900 Euclid Avenue, Cleveland, OH44106–4976, USAView further author information
Pages 429-439 | Published online: 18 Jun 2012

References

  • Collins F . The Language of Life: DNA and the Revolution in Personalized Medicine. HarperCollins, NY, USA (2010).
  • Xu L , ZhengH, SedmakD et al. The re-emerging concept of personalized healthcare. Per. Med. 5(5) , 457–469 (2008).
  • Guyer M , CollinsF. The human genome project and the future of medicine. Am. J. Dis. Child.147 , 1145–1152 (1993).
  • Zerhouni E . The NIH roadmap. Science302(5642) , 63–72 (2003).
  • Khoury M , GwinnM, BurkeW et al. Will genomics widen or help heal the schism between medicine and public health? Am. J. Prevent. Med. 33(4) , 310–317 (2007).
  • Collins F , GreenE, GuttmacherA et al. A vision for the future of genomics research. Nature 422(6934) , 835–847 (2003).
  • Hunter D , KhouryM, DrazenJ. Letting the genome out of the bottle – will we get our wish? N. Engl. J. Med.358(2) , 105–107 (2008).
  • Janssens A , GwinnM, BradleyL et al. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet. 82(3) , 593–599 (2008).
  • Offit K . Genomic profiles for disease risk. JAMA299(11) , 1353–1355 (2008).
  • Guttmacher A , CollinsF, CarmonaR. The family history – more important than ever. N. Engl. J. Med.351(22) , 2333–2336 (2004).
  • Kaput J . Nutrigenomics research for personalized nutrition and medicine. Curr. Opin. Biotechnol.19(2) , 110–120 (2008).
  • Nicholson J , HolmesE, WilsonI. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Micro.3(5) , 431–438 (2005).
  • Curtin C . First steps for personalized medicine. Genome Technol.40–45 (2008).
  • Hudson K . The health benefits of genomics: out with the old, in with the new. Health Affairs27(6) , 1612–1615 (2008).
  • Taylor P . When consent gets in the way. Nature456 , 32–33 (2008).
  • Burke W , KuszlerP, StarksH et al. Translational genomics: seeking a shared vision of benefit. Am. J. Bioethics 8(3) , 54–56 (2008).
  • Maienschein J , SunderlandM, AnkenyR et al. The ethos and ethics of translational research. Am. J. Bioethics 8(3) , 43–51 (2008).
  • Burke W , PsatyB. Personalized medicine in the era of genomics. JAMA298 , 1682–1684 (2007).
  • Hudson K , JavittG, BurkeW et al. ASHG statement on direct-to-consumer genetic testing in the United States. Am. J. Hum. Genet. 81 , 635–637 (2007).
  • Mcinerney J . Implications of DTC genetic test services for providers. Presented at: Fourth Meeting of the CEERS Investigators. National Human Genome Research Institute, MD, USA, 4 March 2008.
  • Magnus D , ChoM, Cook-DeeganR. Direct-to-consumer genetic tests: beyond medical regulation? Genome Med.1(2) , 17 (2009).
  • McGowan M , FishmanJ, LambrixM. Prescribing risk assessment: clinicians and the promise of personalized medicine. Presented at: Society of Social Studies of Science. Cleveland City Center Hotel, OH, USA, 2–5 November 2011.
  • Hedgecoe A . The politics of personalised medicine – pharmacogenetics in the clinic. Cambridge University Press, Cambridge, UK (2004).
  • Kahn J . How a drug becomes “ethnic”: law, commerce, and the production of racial categories in medicine. Yale J. Health Policy Law Ethics4(1) , 1–46 (2004).
  • Rothstein M , EppsP. Science and society: ethical and legal implications of pharmacogenomics. Nat. Rev. Genet.2 , 228–231 (2001).
  • Smart A , MartinP, ParkerM. Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Bioethics18(4) , 322–343 (2004).
  • Avard D , KnoppersB. Genomic medicine: considerations for health professionals and the public. Genome Med.1(2) , 25 (2009).
  • Rhodes R . Rethinking research ethics. Am. J. Bioethics5(1) , 7–28 (2005).
  • McGowan M , FishmanJ, LambrixM. Personal genomics and individual identities: motivations and moral imperatives of early users. N. Genet. Soc.29(3) , 261–290 (2010).
  • Murphy S , ChurchillS, BryL et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res. 19(9) , 1675–1681 (2009).
  • Powell K , ChristiansonC, CogswellW et al. Educational needs of primary care physicians regarding direct-to-consumer genetic testing. J. Genet. Counsel. 21(3) , 469–478 (2011).
  • Lock M , FreemanJ, ChilibeckG et al. Susceptibility genes and the question of embodied identity. Med. Anthropol. Q. 21(3) , 256–276 (2007).
  • Clarke A , ShimJ, MamoL et al. Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine. Am. Sociol. Rev. 68(2) , 161–194 (2003).
  • Post S . Preventing schizophrenia and Alzheimer disease: comparative ethics. Schizophrenia Res.51(1) , 103–108 (2001).
  • Whitehouse P , JuengstE. Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics. J. Am. Geriatr. Soc.53(8) , 1417–1422 (2005).
  • Kaye C , LaxovaR, LivingstonJ et al. Integrating genetic services into public health: guidance for state and territorial programs from the National Newborn Screening and Genetics Resource Center. Commun. Genet. 4(3) , 175–196 (2001).
  • Juengst E . Population genetic research and screening: conceptual and ethical issues. In: The Oxford Handbook of Bioethics. Steinbock B (Ed.). Oxford University Press, Oxford, UK 471–490 (2006).
  • Cowan RS . Moving up the slippery slope: mandated genetic screening on Cyprus. Am. J. Med. Genet. C Semin. Med. Genet.151C(1) , 95–103 (2009).
  • Harmon A . Couples cull embryos to halt heritage of cancer; The DNA age: choosing genes. The New York Times, 3 September (2006).
  • McDougall G , RosamondM. Personalized medicine: what it means for patient centered healthcare and how to address its current challenges. PWC View13 , 1–8 (2010).
  • Nordgren A , JuengstE. Can genomics tell me who I am? Wssentialistic rhetoric in direct-to-consumer DNA testing. N. Genet. Soc.28(2) , 157–172 (2009).
  • Juengst E . FACE facts: why human genetics will always provoke bioethics. J. Law Med. Ethics32(2) , 267–275 (2004).
  • Lee S . Pharmacogenomics and the challenge of health disparities. Public Health Genomics12(3) , 170–179 (2009).
  • Kohane I . The twin questions of personalized medicine: who are you and whom do you most resemble? Genome Med.1(1) , 1–3 (2009).
  • Ioannidis J . Expectations, validity, and reality in omics. J. Clin. Epidemiol.63(9) , 945–949 (2010).
  • Trusheim M , BerndtE, DouglasF. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov.6(4) , 287–293 (2007).
  • Tayo B , TeilM, TongL et al. Genetic background of patients from a University Medical Center in Manhattan: implications for personalized medicine. PLoS ONE 6(5) , e19166 (2011).
  • Reardon J . Democratic mis-haps: the problem of democratization in a time of biopolitics. BioSocieties2 , 239–256 (2007).
  • Kahn J . Race, pharmacogenomics, and marketing: putting BiDil in context. Am. J. Bioethics6(5) , W1–W5 (2006).
  • Lee SS , CrawleyL. Research 2.0: social networking and direct-to-consumer (DTC) genomics. Am. J. Bioethics9(6–7) , 35–44 (2009).
  • Swan M . Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking. Int. J. Environ. Res. Publich Health6(2) , 492–525 (2009).
  • Kieffer C . Citizen empowerment a developmental perspective. In: Studies in Empowerment: Steps Towards Understanding and Action. Rappaport J, Swift C, Hess R (Eds). The Haworth Press, NY, USA, 9–36 (1984).
  • Raman S , TuttonR. Life, science, and biopower. Sci. Technol. Hum. Values35(5) , 711–734 (2010).
  • Novas C , RoseN. Genetic risk and the birth of the somatic individual. Economy Soc.29(4) , 485–513 (2000).
  • Prainsack B , ReardonJ, HindmarshR et al. Personal genomes: misdirected precaution. Nature 456(7218) , 34–35 (2008).
  • McGowan M , FishmanJ. Using lessons learned from BRCA testing and marketing: what lies ahead for whole genome scanning services. Am. J. Bioeth.8(6) , 18–20 (2008).
  • Harvey A . Genetic risks and healthy choices: creating citizen-consumers of genetic services through empowerment and facilitation. Sociol. Health Illness32(3) , 365–381 (2010).
  • Herzlich C , PierretJ. Illness and self in society. Johns Hopkins University Press, MD, USA (1987).
  • Gieryn T . Boundary-work and the demarcation of science from non-science: strains and interests in professional ideologies of scientists. Am. Sociol. Rev.48(6) , 781–795 (1983).
  • Clarke A . A social worlds research adventure: the case of reproductive science. In: Theories of Science in Society. Cozzens S, Gieryn T (Eds). Indiana University Press, IN, USA, 23–50 (1990).
  • Clarke A , StarS. The social worlds/arenas framework as a theory-methods package. In: Handbook of Science and Technology Studies. Hackett E, Amsterdamska O, Lynch M, Wacjman J (Eds). MIT Press, Cambridge, MA, USA, 113–137 (2007).
  • Strauss A . A social world perspective. In: Studies in Symbolic Interaction (Volume 1). Denzin N (Ed.). JAI Press, CT, USA, 119–128 (1978).
  • Strauss A , CorbinJ. Basics of qualitative research: Grounded theory procedures and techniques. SAGE Publications, CA, USA (1990).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.